Juan R. Madoz-Rodriguez

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Overcoming access barriers in European CAR-T therapy: the role of decentralized manufacturing and the EASYGEN framework.

Overcoming access barriers in European CAR-T therapy: the role of decentralized manufacturing and the EASYGEN framework.

Journal: Cytotherapy
Published: April 01, 2026

Improving CRISPR-Cas9 Screens in CAR T Cells: A Refined Method for Library Preparation.

Improving CRISPR-Cas9 Screens in CAR T Cells: A Refined Method for Library Preparation.

Journal: Journal of visualized experiments : JoVE
Published: January 19, 2026

Genetic Engineering in CAR T Cells for Solid Tumors: Current State, Barriers and Future Developments.

Genetic Engineering in CAR T Cells for Solid Tumors: Current State, Barriers and Future Developments.

Journal: Human gene therapy
Published: August 29, 2025

Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma.

Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma.

Journal: Blood neoplasia
Published: August 19, 2025

Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113).

Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113).

Journal: Frontiers in genome editing
Published: July 16, 2025

IRF2 is an Essential Transcription Factor with Pathogenic and Prognostic Impact in Multiple Myeloma.

IRF2 is an Essential Transcription Factor with Pathogenic and Prognostic Impact in Multiple Myeloma.

Journal: Blood
Published: April 01, 2025

IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

Journal: Blood
Published: April 01, 2025

Characterization of the bone marrow architecture of multiple myeloma using spatial transcriptomics.

Characterization of the bone marrow architecture of multiple myeloma using spatial transcriptomics.

Journal: Communications biology
Published: March 21, 2025

European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoring.

European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoring.

Journal: Frontiers in immunology
Published: January 27, 2025

Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma.

Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma.

Journal: Blood
Published: October 30, 2024

Generation and GMP scale-up of human CAR-T cells using non-viral Sleeping Beauty transposons for B cell malignances.

Generation and GMP scale-up of human CAR-T cells using non-viral Sleeping Beauty transposons for B cell malignances.

Journal: Molecular therapy. Methods & clinical development
Published: October 15, 2024

Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML.

Discovery and preclinical development of a SdAb-based CAR-T technology for targeting CD33 in AML.

Journal: Molecular therapy. Oncology
Published: October 15, 2024
Showing 1-12 of 56

Last Updated: 09/26/2026